multi-array platform Search Results


90
Meso Scale Diagnostics LLC ht multi-array electro-chemiluminescence detection plate-format platform
Ht Multi Array Electro Chemiluminescence Detection Plate Format Platform, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ht multi-array electro-chemiluminescence detection plate-format platform/product/Meso Scale Diagnostics LLC
Average 90 stars, based on 1 article reviews
ht multi-array electro-chemiluminescence detection plate-format platform - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Pain Therapeutics multi-well microelectrode array (mea) platform
hiPSC nociceptor growth, neural activity, Z′, and robust Z′ factors on a 48-well <t>MEA</t> plate hiPSC nociceptors were cultured on a 48-well <t>microelectrode</t> array (MEA) plate for 4 weeks. (A) Representative micrographs of hiPSC nociceptors spot seeded at different cell densities (2,000, 35,000, and 65,000 cells/well) and two time points (day 2 and day 28). These micrographs were imaged at 100× magnification. (B–E) Across the 4 weeks of culture, cells were evaluated for (B) total spike count per well; (C) mean firing rate per well; (D) impedance, a measure of cell viability of hiPSC nociceptors; and (E) active electrode yield (AEY), indicating the percentage of electrodes successfully recording neural activity. At the 28 day time point, cells were challenged with inhibitors, and the Z′ and robust Z′ factors were calculated to measure the quality of the assay. (F and G) Z′ (F) and robust Z′ (G) factors were calculated at different densities, showing high quality with the robust Z′ factor at several seeding densities. (H) Scatterplots comparing well total spike count data before (blue) and 2 h post treatment with 500 μM lidocaine (pink) for a representative density of 35,000 cells/well. (I) Normal quantile-quantile (QQ) plot assessing the normality of data distribution before and after lidocaine treatment (five wells for each density). Next, two independent experiments were conducted to evaluate the Z′ and robust Z′ of the assay to three neuronal inhibitors (lidocaine, tetrodotoxin [TTX], and huwentoxin [HWTX]) for cells at 28 days in culture at 35,000 cells/well. (J and K) Z′ factor (J) and the robust Z′ values (K) for different inhibitors in experiment 1 (12 wells for each inhibitor). (L and M) Z′ factor (L) and the robust Z′ values (M) for different blockers in experiment 2 using 35,000/well (12 wells for each inhibitor). 0.5 dotted lines represent the Z′ threshold for a “good” quality assay. Data from these experiments represent three distinct sets of experiments, including two confirmatory experiments as shown. Data from (B)–(E) are presented as mean ± SEM (standard error of the mean).
Multi Well Microelectrode Array (Mea) Platform, supplied by Pain Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/multi-well microelectrode array (mea) platform/product/Pain Therapeutics
Average 90 stars, based on 1 article reviews
multi-well microelectrode array (mea) platform - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Meso Scale Diagnostics LLC multi-array platform
hiPSC nociceptor growth, neural activity, Z′, and robust Z′ factors on a 48-well <t>MEA</t> plate hiPSC nociceptors were cultured on a 48-well <t>microelectrode</t> array (MEA) plate for 4 weeks. (A) Representative micrographs of hiPSC nociceptors spot seeded at different cell densities (2,000, 35,000, and 65,000 cells/well) and two time points (day 2 and day 28). These micrographs were imaged at 100× magnification. (B–E) Across the 4 weeks of culture, cells were evaluated for (B) total spike count per well; (C) mean firing rate per well; (D) impedance, a measure of cell viability of hiPSC nociceptors; and (E) active electrode yield (AEY), indicating the percentage of electrodes successfully recording neural activity. At the 28 day time point, cells were challenged with inhibitors, and the Z′ and robust Z′ factors were calculated to measure the quality of the assay. (F and G) Z′ (F) and robust Z′ (G) factors were calculated at different densities, showing high quality with the robust Z′ factor at several seeding densities. (H) Scatterplots comparing well total spike count data before (blue) and 2 h post treatment with 500 μM lidocaine (pink) for a representative density of 35,000 cells/well. (I) Normal quantile-quantile (QQ) plot assessing the normality of data distribution before and after lidocaine treatment (five wells for each density). Next, two independent experiments were conducted to evaluate the Z′ and robust Z′ of the assay to three neuronal inhibitors (lidocaine, tetrodotoxin [TTX], and huwentoxin [HWTX]) for cells at 28 days in culture at 35,000 cells/well. (J and K) Z′ factor (J) and the robust Z′ values (K) for different inhibitors in experiment 1 (12 wells for each inhibitor). (L and M) Z′ factor (L) and the robust Z′ values (M) for different blockers in experiment 2 using 35,000/well (12 wells for each inhibitor). 0.5 dotted lines represent the Z′ threshold for a “good” quality assay. Data from these experiments represent three distinct sets of experiments, including two confirmatory experiments as shown. Data from (B)–(E) are presented as mean ± SEM (standard error of the mean).
Multi Array Platform, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/multi-array platform/product/Meso Scale Diagnostics LLC
Average 90 stars, based on 1 article reviews
multi-array platform - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
iCell Gene Therapeutics multi-electrode array platforms icell-cm
hiPSC nociceptor growth, neural activity, Z′, and robust Z′ factors on a 48-well <t>MEA</t> plate hiPSC nociceptors were cultured on a 48-well <t>microelectrode</t> array (MEA) plate for 4 weeks. (A) Representative micrographs of hiPSC nociceptors spot seeded at different cell densities (2,000, 35,000, and 65,000 cells/well) and two time points (day 2 and day 28). These micrographs were imaged at 100× magnification. (B–E) Across the 4 weeks of culture, cells were evaluated for (B) total spike count per well; (C) mean firing rate per well; (D) impedance, a measure of cell viability of hiPSC nociceptors; and (E) active electrode yield (AEY), indicating the percentage of electrodes successfully recording neural activity. At the 28 day time point, cells were challenged with inhibitors, and the Z′ and robust Z′ factors were calculated to measure the quality of the assay. (F and G) Z′ (F) and robust Z′ (G) factors were calculated at different densities, showing high quality with the robust Z′ factor at several seeding densities. (H) Scatterplots comparing well total spike count data before (blue) and 2 h post treatment with 500 μM lidocaine (pink) for a representative density of 35,000 cells/well. (I) Normal quantile-quantile (QQ) plot assessing the normality of data distribution before and after lidocaine treatment (five wells for each density). Next, two independent experiments were conducted to evaluate the Z′ and robust Z′ of the assay to three neuronal inhibitors (lidocaine, tetrodotoxin [TTX], and huwentoxin [HWTX]) for cells at 28 days in culture at 35,000 cells/well. (J and K) Z′ factor (J) and the robust Z′ values (K) for different inhibitors in experiment 1 (12 wells for each inhibitor). (L and M) Z′ factor (L) and the robust Z′ values (M) for different blockers in experiment 2 using 35,000/well (12 wells for each inhibitor). 0.5 dotted lines represent the Z′ threshold for a “good” quality assay. Data from these experiments represent three distinct sets of experiments, including two confirmatory experiments as shown. Data from (B)–(E) are presented as mean ± SEM (standard error of the mean).
Multi Electrode Array Platforms Icell Cm, supplied by iCell Gene Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/multi-electrode array platforms icell-cm/product/iCell Gene Therapeutics
Average 90 stars, based on 1 article reviews
multi-electrode array platforms icell-cm - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Meso Scale Diagnostics LLC msd’s ht multi-array electro-chemiluminescence detection plate-format platform
hiPSC nociceptor growth, neural activity, Z′, and robust Z′ factors on a 48-well <t>MEA</t> plate hiPSC nociceptors were cultured on a 48-well <t>microelectrode</t> array (MEA) plate for 4 weeks. (A) Representative micrographs of hiPSC nociceptors spot seeded at different cell densities (2,000, 35,000, and 65,000 cells/well) and two time points (day 2 and day 28). These micrographs were imaged at 100× magnification. (B–E) Across the 4 weeks of culture, cells were evaluated for (B) total spike count per well; (C) mean firing rate per well; (D) impedance, a measure of cell viability of hiPSC nociceptors; and (E) active electrode yield (AEY), indicating the percentage of electrodes successfully recording neural activity. At the 28 day time point, cells were challenged with inhibitors, and the Z′ and robust Z′ factors were calculated to measure the quality of the assay. (F and G) Z′ (F) and robust Z′ (G) factors were calculated at different densities, showing high quality with the robust Z′ factor at several seeding densities. (H) Scatterplots comparing well total spike count data before (blue) and 2 h post treatment with 500 μM lidocaine (pink) for a representative density of 35,000 cells/well. (I) Normal quantile-quantile (QQ) plot assessing the normality of data distribution before and after lidocaine treatment (five wells for each density). Next, two independent experiments were conducted to evaluate the Z′ and robust Z′ of the assay to three neuronal inhibitors (lidocaine, tetrodotoxin [TTX], and huwentoxin [HWTX]) for cells at 28 days in culture at 35,000 cells/well. (J and K) Z′ factor (J) and the robust Z′ values (K) for different inhibitors in experiment 1 (12 wells for each inhibitor). (L and M) Z′ factor (L) and the robust Z′ values (M) for different blockers in experiment 2 using 35,000/well (12 wells for each inhibitor). 0.5 dotted lines represent the Z′ threshold for a “good” quality assay. Data from these experiments represent three distinct sets of experiments, including two confirmatory experiments as shown. Data from (B)–(E) are presented as mean ± SEM (standard error of the mean).
Msd’s Ht Multi Array Electro Chemiluminescence Detection Plate Format Platform, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/msd’s ht multi-array electro-chemiluminescence detection plate-format platform/product/Meso Scale Diagnostics LLC
Average 90 stars, based on 1 article reviews
msd’s ht multi-array electro-chemiluminescence detection plate-format platform - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Meso Scale Diagnostics LLC 4-plex multi-array electrochemiluminescence platform
hiPSC nociceptor growth, neural activity, Z′, and robust Z′ factors on a 48-well <t>MEA</t> plate hiPSC nociceptors were cultured on a 48-well <t>microelectrode</t> array (MEA) plate for 4 weeks. (A) Representative micrographs of hiPSC nociceptors spot seeded at different cell densities (2,000, 35,000, and 65,000 cells/well) and two time points (day 2 and day 28). These micrographs were imaged at 100× magnification. (B–E) Across the 4 weeks of culture, cells were evaluated for (B) total spike count per well; (C) mean firing rate per well; (D) impedance, a measure of cell viability of hiPSC nociceptors; and (E) active electrode yield (AEY), indicating the percentage of electrodes successfully recording neural activity. At the 28 day time point, cells were challenged with inhibitors, and the Z′ and robust Z′ factors were calculated to measure the quality of the assay. (F and G) Z′ (F) and robust Z′ (G) factors were calculated at different densities, showing high quality with the robust Z′ factor at several seeding densities. (H) Scatterplots comparing well total spike count data before (blue) and 2 h post treatment with 500 μM lidocaine (pink) for a representative density of 35,000 cells/well. (I) Normal quantile-quantile (QQ) plot assessing the normality of data distribution before and after lidocaine treatment (five wells for each density). Next, two independent experiments were conducted to evaluate the Z′ and robust Z′ of the assay to three neuronal inhibitors (lidocaine, tetrodotoxin [TTX], and huwentoxin [HWTX]) for cells at 28 days in culture at 35,000 cells/well. (J and K) Z′ factor (J) and the robust Z′ values (K) for different inhibitors in experiment 1 (12 wells for each inhibitor). (L and M) Z′ factor (L) and the robust Z′ values (M) for different blockers in experiment 2 using 35,000/well (12 wells for each inhibitor). 0.5 dotted lines represent the Z′ threshold for a “good” quality assay. Data from these experiments represent three distinct sets of experiments, including two confirmatory experiments as shown. Data from (B)–(E) are presented as mean ± SEM (standard error of the mean).
4 Plex Multi Array Electrochemiluminescence Platform, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/4-plex multi-array electrochemiluminescence platform/product/Meso Scale Diagnostics LLC
Average 90 stars, based on 1 article reviews
4-plex multi-array electrochemiluminescence platform - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Meso Scale Diagnostics LLC msd multi-array microplate
hiPSC nociceptor growth, neural activity, Z′, and robust Z′ factors on a 48-well <t>MEA</t> plate hiPSC nociceptors were cultured on a 48-well <t>microelectrode</t> array (MEA) plate for 4 weeks. (A) Representative micrographs of hiPSC nociceptors spot seeded at different cell densities (2,000, 35,000, and 65,000 cells/well) and two time points (day 2 and day 28). These micrographs were imaged at 100× magnification. (B–E) Across the 4 weeks of culture, cells were evaluated for (B) total spike count per well; (C) mean firing rate per well; (D) impedance, a measure of cell viability of hiPSC nociceptors; and (E) active electrode yield (AEY), indicating the percentage of electrodes successfully recording neural activity. At the 28 day time point, cells were challenged with inhibitors, and the Z′ and robust Z′ factors were calculated to measure the quality of the assay. (F and G) Z′ (F) and robust Z′ (G) factors were calculated at different densities, showing high quality with the robust Z′ factor at several seeding densities. (H) Scatterplots comparing well total spike count data before (blue) and 2 h post treatment with 500 μM lidocaine (pink) for a representative density of 35,000 cells/well. (I) Normal quantile-quantile (QQ) plot assessing the normality of data distribution before and after lidocaine treatment (five wells for each density). Next, two independent experiments were conducted to evaluate the Z′ and robust Z′ of the assay to three neuronal inhibitors (lidocaine, tetrodotoxin [TTX], and huwentoxin [HWTX]) for cells at 28 days in culture at 35,000 cells/well. (J and K) Z′ factor (J) and the robust Z′ values (K) for different inhibitors in experiment 1 (12 wells for each inhibitor). (L and M) Z′ factor (L) and the robust Z′ values (M) for different blockers in experiment 2 using 35,000/well (12 wells for each inhibitor). 0.5 dotted lines represent the Z′ threshold for a “good” quality assay. Data from these experiments represent three distinct sets of experiments, including two confirmatory experiments as shown. Data from (B)–(E) are presented as mean ± SEM (standard error of the mean).
Msd Multi Array Microplate, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/msd multi-array microplate/product/Meso Scale Diagnostics LLC
Average 90 stars, based on 1 article reviews
msd multi-array microplate - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

90
Meso Scale Diagnostics LLC multi-array plate-format platform quickplex 120 imager
hiPSC nociceptor growth, neural activity, Z′, and robust Z′ factors on a 48-well <t>MEA</t> plate hiPSC nociceptors were cultured on a 48-well <t>microelectrode</t> array (MEA) plate for 4 weeks. (A) Representative micrographs of hiPSC nociceptors spot seeded at different cell densities (2,000, 35,000, and 65,000 cells/well) and two time points (day 2 and day 28). These micrographs were imaged at 100× magnification. (B–E) Across the 4 weeks of culture, cells were evaluated for (B) total spike count per well; (C) mean firing rate per well; (D) impedance, a measure of cell viability of hiPSC nociceptors; and (E) active electrode yield (AEY), indicating the percentage of electrodes successfully recording neural activity. At the 28 day time point, cells were challenged with inhibitors, and the Z′ and robust Z′ factors were calculated to measure the quality of the assay. (F and G) Z′ (F) and robust Z′ (G) factors were calculated at different densities, showing high quality with the robust Z′ factor at several seeding densities. (H) Scatterplots comparing well total spike count data before (blue) and 2 h post treatment with 500 μM lidocaine (pink) for a representative density of 35,000 cells/well. (I) Normal quantile-quantile (QQ) plot assessing the normality of data distribution before and after lidocaine treatment (five wells for each density). Next, two independent experiments were conducted to evaluate the Z′ and robust Z′ of the assay to three neuronal inhibitors (lidocaine, tetrodotoxin [TTX], and huwentoxin [HWTX]) for cells at 28 days in culture at 35,000 cells/well. (J and K) Z′ factor (J) and the robust Z′ values (K) for different inhibitors in experiment 1 (12 wells for each inhibitor). (L and M) Z′ factor (L) and the robust Z′ values (M) for different blockers in experiment 2 using 35,000/well (12 wells for each inhibitor). 0.5 dotted lines represent the Z′ threshold for a “good” quality assay. Data from these experiments represent three distinct sets of experiments, including two confirmatory experiments as shown. Data from (B)–(E) are presented as mean ± SEM (standard error of the mean).
Multi Array Plate Format Platform Quickplex 120 Imager, supplied by Meso Scale Diagnostics LLC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/multi-array plate-format platform quickplex 120 imager/product/Meso Scale Diagnostics LLC
Average 90 stars, based on 1 article reviews
multi-array plate-format platform quickplex 120 imager - by Bioz Stars, 2026-06
90/100 stars
  Buy from Supplier

Image Search Results


hiPSC nociceptor growth, neural activity, Z′, and robust Z′ factors on a 48-well MEA plate hiPSC nociceptors were cultured on a 48-well microelectrode array (MEA) plate for 4 weeks. (A) Representative micrographs of hiPSC nociceptors spot seeded at different cell densities (2,000, 35,000, and 65,000 cells/well) and two time points (day 2 and day 28). These micrographs were imaged at 100× magnification. (B–E) Across the 4 weeks of culture, cells were evaluated for (B) total spike count per well; (C) mean firing rate per well; (D) impedance, a measure of cell viability of hiPSC nociceptors; and (E) active electrode yield (AEY), indicating the percentage of electrodes successfully recording neural activity. At the 28 day time point, cells were challenged with inhibitors, and the Z′ and robust Z′ factors were calculated to measure the quality of the assay. (F and G) Z′ (F) and robust Z′ (G) factors were calculated at different densities, showing high quality with the robust Z′ factor at several seeding densities. (H) Scatterplots comparing well total spike count data before (blue) and 2 h post treatment with 500 μM lidocaine (pink) for a representative density of 35,000 cells/well. (I) Normal quantile-quantile (QQ) plot assessing the normality of data distribution before and after lidocaine treatment (five wells for each density). Next, two independent experiments were conducted to evaluate the Z′ and robust Z′ of the assay to three neuronal inhibitors (lidocaine, tetrodotoxin [TTX], and huwentoxin [HWTX]) for cells at 28 days in culture at 35,000 cells/well. (J and K) Z′ factor (J) and the robust Z′ values (K) for different inhibitors in experiment 1 (12 wells for each inhibitor). (L and M) Z′ factor (L) and the robust Z′ values (M) for different blockers in experiment 2 using 35,000/well (12 wells for each inhibitor). 0.5 dotted lines represent the Z′ threshold for a “good” quality assay. Data from these experiments represent three distinct sets of experiments, including two confirmatory experiments as shown. Data from (B)–(E) are presented as mean ± SEM (standard error of the mean).

Journal: Cell Reports Methods

Article Title: Profiling human iPSC-derived sensory neurons for analgesic drug screening using a multi-electrode array

doi: 10.1016/j.crmeth.2025.101051

Figure Lengend Snippet: hiPSC nociceptor growth, neural activity, Z′, and robust Z′ factors on a 48-well MEA plate hiPSC nociceptors were cultured on a 48-well microelectrode array (MEA) plate for 4 weeks. (A) Representative micrographs of hiPSC nociceptors spot seeded at different cell densities (2,000, 35,000, and 65,000 cells/well) and two time points (day 2 and day 28). These micrographs were imaged at 100× magnification. (B–E) Across the 4 weeks of culture, cells were evaluated for (B) total spike count per well; (C) mean firing rate per well; (D) impedance, a measure of cell viability of hiPSC nociceptors; and (E) active electrode yield (AEY), indicating the percentage of electrodes successfully recording neural activity. At the 28 day time point, cells were challenged with inhibitors, and the Z′ and robust Z′ factors were calculated to measure the quality of the assay. (F and G) Z′ (F) and robust Z′ (G) factors were calculated at different densities, showing high quality with the robust Z′ factor at several seeding densities. (H) Scatterplots comparing well total spike count data before (blue) and 2 h post treatment with 500 μM lidocaine (pink) for a representative density of 35,000 cells/well. (I) Normal quantile-quantile (QQ) plot assessing the normality of data distribution before and after lidocaine treatment (five wells for each density). Next, two independent experiments were conducted to evaluate the Z′ and robust Z′ of the assay to three neuronal inhibitors (lidocaine, tetrodotoxin [TTX], and huwentoxin [HWTX]) for cells at 28 days in culture at 35,000 cells/well. (J and K) Z′ factor (J) and the robust Z′ values (K) for different inhibitors in experiment 1 (12 wells for each inhibitor). (L and M) Z′ factor (L) and the robust Z′ values (M) for different blockers in experiment 2 using 35,000/well (12 wells for each inhibitor). 0.5 dotted lines represent the Z′ threshold for a “good” quality assay. Data from these experiments represent three distinct sets of experiments, including two confirmatory experiments as shown. Data from (B)–(E) are presented as mean ± SEM (standard error of the mean).

Article Snippet: The goal was to leverage the human cellular heterogeneity and neuronal firing of the hiPSC nociceptors to build a strong high-content screening (HCS) assay using a multi-well microelectrode array (MEA) platform for pain therapeutics.

Techniques: Activity Assay, Cell Culture, Microelectrode Array